CellSource Co., Ltd.

Tokyo Stock Exchange 4880.T

CellSource Co., Ltd. Price to Book Ratio (P/B) on January 31, 2025: 2.65

CellSource Co., Ltd. Price to Book Ratio (P/B) is 2.65 on January 31, 2025, a -35.58% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

CellSource Co., Ltd. 52-week high Price to Book Ratio (P/B) is 5.23 on August 26, 2024, which is 97.21% above the current Price to Book Ratio (P/B).
CellSource Co., Ltd. 52-week low Price to Book Ratio (P/B) is 2.38 on January 17, 2025, which is -10.07% below the current Price to Book Ratio (P/B).
CellSource Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 4.06.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Tokyo Stock Exchange: 4880.T

CellSource Co., Ltd.

CEO	Mr. Takashi Sawada
IPO Date	Oct. 29, 2019
Location	Japan
Headquarters	Shibuya Mitake Building
Employees	151
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years